Moisand Fitzgerald Tamayo’s Ionis Pharmaceuticals IONS Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$396K	Hold	5,000	–	–	0.04%	93
2026 Q1	$375K	Hold	5,000	–	–	0.04%	89
2025 Q4	$396K	Hold	5,000	–	–	0.04%	86
2025 Q3	$327K	Hold	5,000	–	–	0.04%	94
2025 Q2	$198K	Hold	5,000	–	–	0.03%	118
2025 Q1	$151K	Buy	+5,000	New	+$164K	0.02%	126

Other funds holding IONS

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return

SOAM

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

Moisand Fitzgerald Tamayo's IONS Position: Q2 2026 in Review

Moisand Fitzgerald Tamayo held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 5,000 shares worth $396K. The position accounts for 0.04% of the portfolio, ranked #93.

Moisand Fitzgerald Tamayo first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. 73 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Moisand Fitzgerald Tamayo held 5,000 shares of Ionis Pharmaceuticals worth $396K as of Q2 2026.
Moisand Fitzgerald Tamayo left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up 0.04% of Moisand Fitzgerald Tamayo's portfolio in Q2 2026, its #93 holding.
Moisand Fitzgerald Tamayo first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
73 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q2 2026, filed 13 Jul 2026.